We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$2.63B
AUM Growth
+$217M
Cap. Flow
+$58.3M
Cap. Flow %
2.22%
Top 10 Hldgs %
32.98%
Holding
947
New
185
Increased
338
Reduced
311
Closed
89

Sector Composition

Rank Sector Weight
1 Healthcare 20.15%
2 Technology 14.41%
3 Financials 7.34%
4 Consumer Discretionary 5.99%
5 Industrials 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQLT icon
326
iShares MSCI Intl Quality Factor ETF
IQLT
$14.2B
$1.02M 0.04%
23,550
-449,188
-95% -$18.6M
BNY
327
Bank of New York Mellon
BNY
$107B
$1.02M 0.04%
11,165
+3,045
+38% +$259K
APTV icon
328
Aptiv
APTV
$10.3B
$1.02M 0.04%
14,883
+11,480
+337% +$711K
CRWD icon
329
CrowdStrike
CRWD
$218B
$1.01M 0.04%
7,920
+484
+7% +$52.5K
SPGI icon
330
S&P Global
SPGI
$120B
$1.01M 0.04%
1,912
+1,073
+128% +$536K
CCL icon
331
Carnival Corporation Ltd
CCL
$39.7B
$1,000K 0.04%
35,546
-12,443
-26% -$266K
HPE icon
332
Hewlett Packard
HPE
$70.5B
$997K 0.04%
48,768
+110
+0.2% +$1.84K
BX icon
333
Blackstone
BX
$110B
$992K 0.04%
6,630
+3,211
+94% +$441K
ALSN icon
334
Allison Transmission
ALSN
$9.82B
$991K 0.04%
10,433
+6,197
+146% +$599K
VMC icon
335
Vulcan Materials
VMC
$36.9B
$983K 0.04%
3,770
+1,264
+50% +$325K
NSC icon
336
Norfolk Southern
NSC
$75.1B
$971K 0.04%
3,793
+2,052
+118% +$484K
ISRG icon
337
Intuitive Surgical
ISRG
$134B
$970K 0.04%
1,786
+123
+7% +$64.3K
ROST icon
338
Ross Stores
ROST
$81.9B
$968K 0.04%
7,591
+2,843
+60% +$395K
GILD icon
339
Gilead Sciences
GILD
$165B
$966K 0.04%
8,709
+869
+11% +$92.5K
UAL icon
340
United Airlines
UAL
$42.1B
$964K 0.04%
12,106
+7,175
+146% +$529K
IYW icon
341
iShares US Technology ETF
IYW
$25.2B
$958K 0.04%
5,530
-929
-14% -$141K
ZBRA icon
342
Zebra Technologies
ZBRA
$17.8B
$957K 0.04%
3,105
+1,076
+53% +$292K
TER icon
343
Teradyne
TER
$59.3B
$955K 0.04%
10,615
-3,310
-24% -$264K
DE icon
344
Deere & Co
DE
$168B
$952K 0.04%
1,873
+34
+2% +$16.6K
APLS
345
DELISTED
Apellis Pharmaceuticals
APLS
$949K 0.04%
54,849
+12,315
+29% +$228K
BPMC
346
DELISTED
Blueprint Medicines
BPMC
$944K 0.04%
7,361
+518
+8% +$53.8K
TXT icon
347
Textron
TXT
$15.4B
$942K 0.04%
+11,728
New +$849K
GSIE icon
348
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
$942K 0.04%
23,743
-504,511
-96% -$19M
VO icon
349
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$939K 0.04%
13,420
-1,004
-7% -$65.9K
COIN icon
350
Coinbase
COIN
$40.5B
$933K 0.04%
2,662
+41
+2% +$9.59K

Similar funds

Pallas Capital Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Pallas Capital Advisors held 947 positions worth $2.63B, up 9% from $2.41B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Pallas Capital Advisors's Q2 2025 filing shows 185 new, 338 increased, 311 reduced and 89 closed positions. Its largest new stake was Capital Group Dividend Value ETF: 163,663 shares worth $6.46M. The largest sale was Goldman Sachs ActiveBeta International Equity ETF, an estimated $19M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

  • Pallas Capital Advisors's largest Q2 2025 buy was Capital Group Dividend Value ETF: 163,663 shares worth $6.46M.
  • Pallas Capital Advisors added most to Schwab Fundamental International Large Company Index ETF in Q2 2025, an estimated $21.7M increase.
  • Pallas Capital Advisors's biggest Q2 2025 reduction was Goldman Sachs ActiveBeta International Equity ETF, cutting an estimated $19M.
  • Pallas Capital Advisors fully exited Synopsys in Q2 2025, selling an estimated $7.4M.
  • Pallas Capital Advisors's ten largest holdings make up 33% of its $2.63B portfolio in Q2 2025.
  • Pallas Capital Advisors opened 185 new positions and closed 89 in Q2 2025.
  • Pallas Capital Advisors's portfolio value rose 9% quarter-over-quarter to $2.63B.

Based on Pallas Capital Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.